Stay updated with breaking news from Mark Bleackley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL)'s Mark Bleackley tells Andrew Scott about a study that investigates the neuro-protective properties of the...
Highlights: Positive phase 2a clinical trial results for IHL-42X with 60% of trial participants experiencing at least a 55% reduction in the Apnoea Hypopnea...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), one of the first ASX-listed companies to make forays into cannabinoid and psychedelic therapeutic drugs,...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL)'s chief scientific officer Mark Bleackley speaks with Proactive soon after completing preliminary data...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL)'s chief scientific officer Mark Bleackley speaks with Proactive soon after completing preliminary data...